Upcoming IPOs
All IPOs

Speciality Medicines IPO Review

BSE SMEListed

Pharmaceuticals · Listed on BSE · 20 Mar 2026 - 24 Mar 2026

Jagat JoshiJagat Joshi
November 2, 2026
Issue Size
29.00 Cr
Price Band
₹117.00 - ₹124.00
Lot Size
1000 Shares
Min Investment
₹2,48,000
GMP
₹0
Subscription
2.27x
₹61.84 Cr
IPO Timeline
IPO OpensDONE
20 Mar 2026
IPO ClosesDONE
24 Mar 2026
Basis of AllotmentDONE
25 Mar 2026
RefundsDONE
27 Mar 2026
Demat CreditDONE
27 Mar 2026
ListingDONE
30 Mar 2026

About Speciality Medicines IPO

Speciality Medicines IPO open date is March 20, 2026 and the IPO will close on March 24, 2026. Speciality Medicines IPO is a Book build Issue. The company to raise around ₹29.14 crores via IPO that comprises fresh issue of ₹29.14 crores and offer for sale up to [.] equity shares with face value of ₹10 each.

Speciality Medicines IPO price band is ₹117 to ₹124 per share. The retail quota is 49%, QIB is 2%, and HNI is 49%. Speciality Medicines IPO to list on BSE on March 30, 2026. The allotment of Speciality Medicines IPO date is March 25, 2026.

The company reported revenue of ₹58.54 crores in 2025 against ₹27.66 crores in 2024. The company reported profit of ₹8.61 crores in 2025 against profit of ₹2.93 crores in 2024. As per the financials the IPO investors should apply the IPO for a long term.

Advertisement
Back to IPO Details

IPO Recommendations

Consensus review from market research firms & brokerage analysts

0
analysts
0
Apply
0
May Apply
0
Neutral
0
Avoid

Speciality Medicines Review

No broker reviews have been published for this IPO yet.

User Reviews

Community Sentiment
Votes submitted by verified retail investors
0
votes
0
Apply
0
May Apply
0
Neutral
0
Avoid

Add Your Review

What is your recommendation for this IPO?

Loading options…

How would you rate this IPO (1 to 5)?

3
Disclaimer:

The IPO reviews, and recommendations published on this page are provided by respective authors, brokers, analysts, and contributors. These views do not represent the views of IPO Watch, its management, or its staff.

IPO Watch does not guarantee about the information or recommendations provided by third-party contributors. Use this content for informational and educational purposes only.

Investors are advised to do their own research, check offer documents, and consult a qualified financial adviser before making investment decisions.

IPO Watch reserves the right to review, modify, or remove any content that does not meet the editorial guidelines.

Advertisement

Frequently Asked Questions (FAQ)

Comments0

Join the discussion

Please sign in to leave a comment or reply.

Sorted by